Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.00 (0.00%)
Bid:
2.80
Ask:
3.20
Spread: 0.40 (14.286%)
Market Cap: £5.64m
SEED Live PriceLast checked at - London Stock Exchange

Intraday Seed Share Chart

Updated Key Information Document

20 Aug 2021 07:00

RNS Number : 1996J
Seed Innovations Limited
20 August 2021
 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

20th August 2021

SEED Innovations Ltd ("SEED" or the "Company")

Updated Key Information Document

 

SEED Innovations Ltd, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, is pleased to announce that the Company has prepared an updated Key Information Document ("KID") which can now be viewed on SEED's website via the following link: https://seedinnovations.co/investor-centre/corporate-documents

***ENDS***

For further information on the Company please visit www.seedinnovations.co or contact:

Ed McDermott /

Lance de Jersey

SEED Innovations Ltd

Email:   info@seedinnovations.co

 

James Biddle /

Roland Cornish

Beaumont Cornish Limited,

Nomad

 

Tel: +44 (0) 207 628 3396

Isabella Pierre /

Damon Heath

Shard Capital Partners LLP

 

T: +44 (0)20 7186 9927

Catherine Leftley /

Isabel de Salis

St Brides Partners Ltd,

Financial PR

 

Email: info@stbridespartners.co.uk

 

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKCBQKBKDAFD
Date   Source Headline
21st Mar 202410:25 amRNSTransaction in Own Shares & TVR
21st Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20242:30 pmRNSInvestee Company Update: Northern Leaf
13th Mar 202412:23 pmRNSTransaction in Own Shares & TVR
12th Mar 202412:19 pmRNSTransaction in Own Shares & TVR
11th Mar 202411:27 amRNSTransaction in Own Shares & TVR
7th Mar 20241:09 pmRNSTransaction in Own Shares
7th Mar 20249:08 amRNSTransaction in Own Shares & TVR
29th Feb 20249:00 amRNSContinuation of Existing Share Buy-Back Programme
20th Feb 20244:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
19th Feb 20247:00 amRNSTransaction in Own Shares & TVR
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares & TVR
8th Feb 20247:00 amRNSTransaction in Own Shares & TVR
7th Feb 20247:00 amRNSTransaction in Own Shares & TVR
5th Feb 20242:00 pmRNSTransaction in Own Shares & TVR
1st Feb 20243:22 pmRNSTransaction in Own Shares & TVR
1st Feb 202410:06 amRNSInvestee Company Update: Little Green Pharma Ltd
26th Jan 20247:00 amRNSTransaction in Own Shares & TVR
25th Jan 20243:03 pmRNSInvestee Company Update: Avextra AG Raises €3.3m
25th Jan 20247:00 amRNSTransaction in Own Shares & TVR
24th Jan 20247:00 amRNSInvestee Company Update: Avextra AG
23rd Jan 20247:00 amRNSInvestee Company Update: Avextra AG
23rd Jan 20247:00 amRNSTransaction in Own Shares & TVR
22nd Jan 20247:00 amRNSCEO Presenting at Proactive One2One Investor Forum
19th Jan 20246:23 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTransaction in Own Shares & TVR
28th Dec 20237:00 amRNSTransaction in Own Shares & TVR
22nd Dec 202311:10 amRNSInvestee Company Updates
19th Dec 20237:00 amRNSTransaction in Own Shares & TVR
18th Dec 20237:00 amRNSTransaction in Own Shares & TVR
13th Dec 20237:00 amRNSTransaction in Own Shares & TVR
12th Dec 20237:00 amRNSTransaction in Own Shares & TVR
11th Dec 20237:00 amRNSTransaction in Own Shares & TVR
8th Dec 20237:00 amRNSTransaction in Own Shares & TVR
7th Dec 20234:52 pmRNSInvestee Company Update: Little Green Pharma Ltd
7th Dec 20237:00 amRNSTransaction in Own Shares & TVR
5th Dec 20239:20 amRNSInvestee Company Update: Clean Food Group
5th Dec 20237:00 amRNSTransaction in Own Shares & TVR
4th Dec 20238:44 amRNSTransaction in Own Shares & TVR
30th Nov 202312:44 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th Nov 20237:00 amRNSTransaction in Own Shares and TVR
29th Nov 20237:00 amRNSTransaction in Own Shares & TVR
28th Nov 202312:51 pmRNSInvestee Company Update: Clean Food Group
28th Nov 20239:00 amRNSTransaction in Own Shares & TVR
24th Nov 20237:00 amRNSTransaction in Own Shares & TVR
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20232:29 pmRNSInterim Results
20th Nov 202310:18 amRNSInvestee Company Update: Little Green Pharma Ltd
20th Nov 20237:00 amRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.